Articles tagged with Vaccination
Scientists at NIST developed a measurement method to quantify the slowing down of molecular rattling in preservative formulations. The team discovered a general pattern of behavior that applies to various materials, promising better preservation and extended shelf life for vaccines, food, and other biological materials.
Researchers found that HAART contributes to pulmonary hypertension in HIV-infected patients by impairing blood vessel-lining endothelial cell function. A novel treatment for chronic hypoxic pulmonary hypertension (PHTN) involves neprilysin, which protects against PHTN by regulating neural signaling molecules.
Researchers discovered how meningitis bacteria use a protein to disguise themselves as human cells, evading the immune system. This finding could lead to improved vaccines against meningitis B, which accounts for most UK cases. The bacterial protein can be modified to generate a stronger immune response.
Researchers found no increased risk of Guillain-Barré syndrome after HPV vaccination, but cases still warrant careful monitoring. The study analyzed data from the Vaccine Adverse Event Reporting System and reported 36 cases within six weeks of vaccination.
Researchers have created a new test to better predict whether a given vaccine candidate will protect or harm patients with dengue fever. The test aims to address the deadly complications associated with the disease, which affects 100 million people annually and claims 22,000 lives yearly.
Researchers find voluntary vaccination effective in containing outbreaks of diseases like smallpox and SARS due to social network effects. Neighborhood size plays a crucial role in determining the effectiveness of voluntary vaccination programs.
Despite high awareness, African-Americans are underrepresented in HPV vaccination due to misinformation, lack of education, and societal pressures. The survey found that most participants believed the vaccine was safe and effective, but caregivers were often unaware of its benefits.
A recent review summarizes studies refuting the claim of a vaccine-autism link, instead attributing symptoms to coincidental timing or other factors. Immunization rates are crucial in preventing outbreaks of vaccine-preventable diseases.
A pediatric vaccine has been found to be highly effective in preventing pneumococcal meningitis, a deadly disease that affects young children. The vaccine, PCV7, protects against seven common pneumococcal types, accounting for over 80% of cases in young children, and has been shown to decrease rates by 30-64% in both children and adults.
A new vaccine aims to treat and stop prostate cancer by targeting the unique sugar molecules expressed on cancer cells. The vaccine has shown promise in preclinical studies and could potentially be used against other types of carcinomas such as breast, lung, and ovarian cancers.
The American College of Physicians emphasizes the need for enhanced infection control practices to prevent viral hepatitis outbreaks. Researchers also stress the importance of proper antibiotic treatment for health care-associated pneumonia, highlighting its more serious nature compared to community-acquired pneumonia.
Researchers at UT School of Public Health found a strong link between PVL and severe CA MRSA infections. Using animal models, they identified PVL as a potential vaccine target against these deadly strains.
Scientists identify a common vulnerability in rotaviruses, enabling the development of a broad-spectrum treatment for severe diarrheal diseases. This breakthrough could lead to improved vaccines and medications to prevent or treat rotavirus infections.
A recent Mayo Clinic study found adults with asthma are seven times more likely to develop invasive pneumococcal diseases, a serious and potentially fatal condition. The researchers recommend including asthma as an indication for pneumococcal vaccination in adults, which could significantly reduce instances of this disease.
Experts outline three rules for selecting technological fixes, emphasizing the importance of cause-effect relationships, clear benefits, and standardized technical cores. Vaccines serve as a successful example, while literacy education highlights the challenges of finding effective solutions.
The study found that global child immunization coverage is significantly lower than reported by individual nations or WHO/UNICEF estimates. The researchers estimated the coverage of three doses of diphtheria, tetanus, and whooping cough vaccine (DPT3) based on surveys using all available data from 193 countries between 1986-2006.
A new study found that a fractional dose of a commonly used meningitis vaccine is as effective as the full dose, allowing for more efficient use of scarce vaccine resources. The research was conducted in Uganda and suggests that using 1/5 doses could be an alternative in mass vaccination campaigns during epidemics.
The high cost of childhood vaccines leads to financial strain for physicians, with prices varying widely across medical practices. Many physicians are paying too much for vaccines while receiving too little reimbursement, but new data can help improve these areas.
Researchers at Heidelberg University Hospital developed a vaccine that prevents multiple sclerosis in mice by suppressing the harmful immune response. The treatment uses autologous immune cells treated with mitomycin and expresses a self-protein from the nervous system, rendering them non-reactive to the disease.
Researchers from Cedars-Sinai Medical Center presented several studies on brain-immune interactions, including the role of cilia in regulating hippocampal neurogenesis and the use of dendritic cells to boost anti-glioma immune responses. These findings have important implications for our understanding of the brain's immune system and p...
A new study finds that accelerating the pertussis vaccine schedule by two weeks could prevent at least 1,236 cases of the disease each year. This shift would also reduce hospitalizations and deaths attributed to pertussis, a disease that can be life-threatening in young infants.
A new cancer vaccine has elicited an immune response in most patients with bowel, kidney and prostate cancer, suggesting potential clinical benefit. The vaccine, TroVax, is well-tolerated and may provide survival benefits to patients.
Researchers at Saint Louis University have identified an investigational vaccine that induces a better immune response and is more effective at protecting against tuberculosis. The vaccine uses a weakened TB germ from one of the strains of the current tuberculosis vaccine.
Researchers have developed a novel delivery system that significantly enhances vaccine effectiveness while tailoring it based on the desired type of immune response. Using RNA molecules, their system achieved immune responses five to 50 times stronger than traditional vaccines in mice studies.
Researchers at Aberystwyth University have licensed a discovery of a protein that can 'wake up' dormant Mycobacterium tuberculosis bacteria, potentially leading to the development of a more effective vaccine. The Aeras Global TB Vaccine Foundation plans to take its recombinant BCG (AERAS-407) vaccine to clinical trial in 2009.
A national survey reveals that nearly one in four parents believe vaccines cause autism, leading to fewer vaccinations and a growing number of measles infections. The study's findings highlight the lingering fear and confusion surrounding vaccines, despite overwhelming scientific evidence debunking the link.
A randomized clinical trial found that changing dosing and administration of an anthrax vaccine to intramuscular injection resulted in fewer adverse events while maintaining comparable effectiveness. The study also discovered that a reduced 3-dose schedule was noninferior to the licensed regimen.
A study of 349 children with MS and 2,941 without the disease found that hepatitis B vaccination does not increase multiple sclerosis risk. However, a specific type of vaccine was linked to symptoms in vaccinated children with MS, three or more years after vaccination.
Researchers have identified a key role for cytokine interleukin 17 in immune system detection of pneumococcus. This discovery may help develop an effective and affordable vaccine for the disease, which affects young children and the elderly.
A study by the University of Nottingham aims to identify bacterial antigens that could lead to an effective vaccine against Bovine Mastitis. The researchers will use state-of-the-art molecular technology to determine which proteins are essential for infection.
A new breast cancer vaccine has been tested in mice and shown to completely eliminate HER2-positive tumors, even those resistant to current therapy. The vaccine uses activated immunity to target the HER2 receptor, potentially eliminating the need for existing therapies.
A study published in Public Library of Science found no association between the MMR vaccine and the onset of autism or gastrointestinal symptoms in children. The study analyzed bowel tissues from 25 children with autism and GI disturbances, as well as 13 controls, and found no presence of measles virus RNA in either group.
Researchers will develop oral vaccines against tetanus and rotavirus, targeting vulnerable infants and young children. The goal is to create a vaccine that doesn't contain live bacteria and has fewer side effects.
A team of vaccine safety experts has developed a step-by-step tool to identify children with allergic reactions to vaccines and provide safe immunization plans. Most children with known or suspected vaccine allergies can be safely vaccinated with proper monitoring and precautions, according to the study.
A CMAJ study found significantly higher rates of anaphylaxis in young women after HPV vaccination, with a rate of 2.6 per 100,000 doses administered. However, the overall rates were low and no serious lasting effects were observed.
Cervical cancer control is becoming feasible in developing countries due to highly effective vaccines and promising new screening tests. The monograph presents the best global thinking on cervical cancer prevention with vaccination and screening, evaluating cost-effectiveness and affordability.
Researchers at the Institute for Animal Health are developing complex models to understand how bluetongue virus spreads among livestock. By analyzing midge numbers, biting behavior, and weather patterns, they aim to provide farmers with critical information on when to move animals and implement best practices for controlling the spread...
A UCF professor has developed an oral vaccine that shows high effectiveness against the plague, which could provide a practical solution in the event of a bioterror attack. The vaccine is more expensive to produce than traditional injectable vaccines but offers a cheap and accessible alternative.
Researchers developed an injectable vaccine grown in genetically engineered plants to treat follicular B-cell lymphoma, a chronic and incurable disease. The plant-grown vaccines lack side effects and could allow earlier, more aggressive management of the cancer.
Researchers at Duke University Medical Center found that HIV-1 cripples the immune system earlier than previously believed, with significant cell death occurring within five to seven days after infection. The study suggests a new approach to vaccine design, requiring multiple arms of the immune system to be activated and targeted.
In a bid to control an extensive plague outbreak in South Dakota, biologists are vaccinating endangered black-footed ferrets with a vaccine given by the U.S. Geological Survey. The vaccine has been used during a major plague epizootic for the first time and is administered to prairie dogs and ferrets through initial shots and boosters.
Researchers found a correlation between the intensity of a patient's immune response and clinical outcomes in brain cancer patients. The study showed that stronger immune responses were associated with longer survival times and improved treatment outcomes.
The addition of hormone therapy following vaccine treatment improved overall survival in patients with castration-resistant prostate cancer. Vaccines can be safely and effectively combined with other therapies, including hormones.
The researchers have developed a biologically engineered organism that can effectively deliver an antigen in the body using live salmonella bacterium. The new method is a major step forward in developing a means of biological containment for vaccine delivery, making vaccines more affordable for developing countries.
Researchers have developed a plant-derived vaccine against Alzheimer's disease using transgenic tomatoes expressing human beta-amyloid protein. The study showed a strong immune response in mice, but the potency of the vaccine needs to be increased.
A new vitespen vaccine was tested on post-operative kidney cancer patients, but showed no significant improvement in recurrence-free survival. In early stage disease, patients receiving the vaccine had a lower risk of recurrence, but this finding requires further validation.
Researchers at the Uniformed Services University of the Health Sciences have been awarded a $5.6 million grant to develop vaccines and treatments for Nipah and Hendra viruses. The grant will support collaboration with Australian researchers to test vaccines and therapeutics, which have shown promising results in previous studies.
The US FDA has approved KINRIX, a combination vaccine that protects against four serious diseases: diphtheria, tetanus, pertussis and polio. Clinical studies show similar protection to separately administered vaccines with a comparable safety profile.
Researchers at Temple University found that addressing ER workers' fears and concerns through targeted messages can increase vaccination rates. The study used perceptual mapping to analyze respondents' attitudes toward vaccination, revealing significant shifts under varying levels of threat.
A new vaccine patch has shown promising results in protecting travelers from diarrhoea, with 75% efficacy against moderate-to-severe episodes. The patch also reduced the duration and severity of illness in those who became sick, offering a new option for prevention and treatment.
Researchers have discovered a group of 24 linked to virulence in Brucella abortus strain S19, which has been used as a vaccine for cattle. The study's findings may explain why other strains cause disease and trigger abortion in livestock. This understanding could aid in combating brucellosis and its potential applications in bioterrorism.
A new vaccine targeting more common pneumococcal strains is on the horizon to replace PCV7, which has seen a rise in non-vaccine strain IPD rates by 40%. The vaccine's effectiveness against resistant bacteria is currently being tested.
Researchers develop a technique to coat viruses with proteins, allowing for easier tracking and treatment of infectious diseases. This breakthrough could lead to new treatments for cancer, cardiovascular, metabolic, and inherited disorders.
A vaccine created by University of Rochester Medical Center scientists prevents the development of Alzheimer’s disease-like pathology in mice. The vaccinated mice demonstrated normal learning skills and functioning memory despite being genetically designed to develop an aggressive form of the disease.
Researchers at UT Medical School in Houston found that knowing a blood relative with shingles doubles one's risk of getting the condition. The study recommends vaccination for individuals with family history to prevent shingles outbreaks.
A new therapeutic vaccine has shown promising results in prolonging survival and improving the quality of life for men with metastatic prostate cancer. The adenovirus/PSA vaccine demonstrated strong immune responses to PSA, leading to improved patient outcomes.
Researchers at ETH Zurich identify a unique invasion strategy used by the vaccinia virus, exploiting cellular waste disposal mechanisms and evading immune response. The discovery sheds light on a new mechanism of action for this virus, which could inform the development of new antiviral agents.
A new, simplified economical method of giving rabies vaccine has been shown to stimulate anti-rabies antibodies just as effectively as the current standard vaccine regimen. The 4-site intradermal regimen is cheaper and more practical, with wider safety margins and suitability for use in financial-constrained areas.
Geisinger's Electronic Health Record program improves blood sugar and cholesterol levels, increases vaccination compliance, and boosts tobacco cessation rates. The program also enhances patient engagement through its Internet portal, MyGeisinger.
Researchers have successfully tested Ebola vaccines in primates, triggering a cell-mediated response and producing effective protection. The candidates are now set to be tested on humans for the first time, offering hope for controlling outbreaks and protecting healthcare workers.